
Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
By BY KATIE THOMAS from NYT Health https://ift.tt/345UAfL
via IFTTT
your-feed-science, Clinical Trials, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Hospitals, Research
Source New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét